Martin Shkreli Says ‘Of Course’ He’d Raise Drug Price Again
- Only regret is not fully predicting blowback to strategy
- Turing raised Daraprim more than 50-fold under Shkreli
Shkreli: Price Increase Has Stuck, Happy With That
This article is for subscribers only.
Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion and heightened by the U.S. presidential election, although he conceded he could have predicted the blowback better.
“In terms of regret, maybe not seeing that as acutely would’ve been a minor regret,” Shkreli said during an interview on Bloomberg TV Friday. “But because the price increase has stuck, so to speak, I don’t really, that’s the main mission -- which was to raise the price and have it generate increased revenue -- that’s happened, so I’m happy with respect to that.”